No link to cardiac valvulopathy was seen in cabergoline treated patients
<p><strong>Objective:</strong> To evaluate the association between use of cabergoline in patients with prolactinoma and risk of developing clinically relevant cardiac valvular disease.</p> <p><strong>Method:</strong> This was a descriptive cross sectional st...
मुख्य लेखकों: | K Dharshini, Noel Somasundaram, HMDPK Senevirathna, S Raj Kumar |
---|---|
स्वरूप: | लेख |
भाषा: | English |
प्रकाशित: |
Sri Lanka College of Endocrinologists
2012-10-01
|
श्रृंखला: | Sri Lanka Journal of Diabetes Endocrinology and Metabolism |
विषय: | |
ऑनलाइन पहुंच: | https://sjdem.sljol.info/articles/4775 |
समान संसाधन
-
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
द्वारा: Shruti Khare, और अन्य
प्रकाशित: (2017-01-01) -
Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
द्वारा: Annabelle G Hayes, और अन्य
प्रकाशित: (2023-01-01) -
Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
द्वारा: Youngki Lee, और अन्य
प्रकाशित: (2014-09-01) -
Spontaneous reduction of prolactinoma post cabergoline withdrawal
द्वारा: Sampath Kumar Venkatesh, और अन्य
प्रकाशित: (2012-01-01) -
The course of pregnancy and delivery in patients with prolactinoma during treatment with cabergoline
द्वारा: Larisa Dzeranova, और अन्य
प्रकाशित: (2016-11-01)